FindTrial
Sign In

Clinical outcomes of radiotherapy with high dose boost to lymph node positive carcinoma cervix - A observational study

Clinical outcomes of volumetric modulated arc radiotherapy with high dose simultaneous integrated boost in lymph node positive carcinoma cervix– A prospective observational study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073595
Enrollment
67
Registered
2024-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Sri Venkateshwara Institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age : 18 years or older Biopsy proven carcinoma cervix patients International Federation of Gynaecology and Obstetrics (FIGO) stage : stage IIIC Eastern Cooperative Oncology Group (ECOG) Performance Status Scale (PSS) 0-2 Patients who have given approval for written informed consent Patients who are eligible to receive chemotherapy

Exclusion criteria

Exclusion criteria: ECOG PSS 3-4 Post operative carcinoma cervix patients Pregnant and lactating mothers Patients who have not given approval for informed consent

Design outcomes

Primary

MeasureTime frame
To evaluate tumour response in radiological node positive carcinoma cervix patients receiving simultaneous integrated boost along with volume based brachytherapyTimepoint: Day 1 to 15 months from start of treatment—

Secondary

MeasureTime frame
Acute bowel, bladder & rectal toxicities Late bowel ,bladder & rectal toxicities Progression free survival Overall survival Timepoint: Day 1 to 15 months after start of treatment—

Countries

India

Contacts

Public ContactAvisapogu Baba Bharath

Department of Radiation Oncology ,Sri Venkateswara Institute of Medical Sciences,Tirupati

doctorrt12@gmail.com9701951615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026